• Mon. May 23rd, 2022

Thyrotropin-Releasing Hormone Receptors

  • Home
  • Ipilimumab (YERVOY?; Bristol-Myers Squibb, Princeton, NJ) is certainly a monoclonal antibody against cytotoxic T-lymphocyte antigen 4 (CTLA-4), which can be an immune system checkpoint regulator [3,32]